244 related articles for article (PubMed ID: 27312584)
1. Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer.
Buti S; Ciccarese C; Iacovelli R; Bersanelli M; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R; Tortora G; Massari F
Future Oncol; 2016 Sep; 12(17):1971-4. PubMed ID: 27312584
[TBL] [Abstract][Full Text] [Related]
2. Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 - kidney cancer.
Buti S; Ciccarese C; Iacovelli R; Bersanelli M; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R; Tortora G; Massari F
Future Oncol; 2016 Sep; 12(17):1967-70. PubMed ID: 27312426
[TBL] [Abstract][Full Text] [Related]
3. Inside the 2015 ASCO Genitourinary Cancers Symposium.
Santoni M; Massari F; Iacovelli R; Ciccarese C; Verri E; Burattini L; Montironi R; Nolè F; Tortora G; Cascinu S
Future Oncol; 2015; 11(13):1859-62. PubMed ID: 26161923
[TBL] [Abstract][Full Text] [Related]
4. Novel ADCs and combination therapy in urothelial carcinoma: latest updates from the 2023 ASCO-GU Cancers Symposium.
Yu J; Wu S; Li R; Jiang Y; Zheng J; Li Z; Li M; Xin K; Guan X; Li S; Chen X
J Hematol Oncol; 2023 Jul; 16(1):85. PubMed ID: 37507780
[TBL] [Abstract][Full Text] [Related]
5. Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice.
Bianconi M; Santoni M; Massari F; Faloppi L; Del Prete M; Giampieri R; Ciccarese C; Modena A; Tortora G; Scartozzi M; Cascinu S
Future Oncol; 2014 Nov; 10(14):2103-6. PubMed ID: 25471023
[TBL] [Abstract][Full Text] [Related]
6. Joint genitourinary cancer symposium between Egyptian and American centers.
Zaghloul MS
Expert Rev Anticancer Ther; 2011 May; 11(5):697-9. PubMed ID: 21554043
[TBL] [Abstract][Full Text] [Related]
7. Highlights from the ASCO Genitourinary Symposium 2014: focus on renal and prostate cancer.
Iacovelli R; Santoni M; de Braud F; Cascinu S; Procopio G
Expert Rev Anticancer Ther; 2014 Dec; 14(12):1407-9. PubMed ID: 25159199
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on Geriatric Oncology Research presented at the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium.
Shen J; Prentice M; Pollock Y; Franca M; Kanesvaran R
J Geriatr Oncol; 2019 Jul; 10(4):523-525. PubMed ID: 30982753
[No Abstract] [Full Text] [Related]
9. Highlights from The 2006 American Society of Clinical Oncology Prostate Cancer Symposium San Francisco, CA; February 24-26, 2006.
Muneer S; Reddy GK; Ranganathan A; Shivakumar L
Clin Genitourin Cancer; 2006 Mar; 4(4):240-5. PubMed ID: 16729905
[No Abstract] [Full Text] [Related]
10. Translational challenges from the 2014 Gastrointestinal Cancers Symposium: toward a true tailored therapy through effective research.
Aprile G; Giuliani F; Cordio S; Sartore-Bianchi A; Bencardino K; Ongaro E; Martines C; Giampieri R; Bordonaro R; Siena S; Cascinu S; Scartozzi M
Future Oncol; 2014 May; 10(7):1125-8. PubMed ID: 24947252
[TBL] [Abstract][Full Text] [Related]
11. American Urological Association Annual Meeting--AUA 2004. 8-13 May 2004, San Francisco, CA, USA.
Jamison J
IDrugs; 2004 Jul; 7(7):639-41. PubMed ID: 15243863
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy in urologic oncology].
Deville JL
Prog Urol; 2011 Nov; 21(11):816-21. PubMed ID: 22032608
[TBL] [Abstract][Full Text] [Related]
13. [Pharmaceutical treatment of advanced urinary bladder cancer: new developments in 2014].
Schmid SC; Gschwend JE; Retz M
Urologe A; 2014 Oct; 53(10):1535-42. PubMed ID: 25234951
[TBL] [Abstract][Full Text] [Related]
14. Immunologic checkpoints blockade in renal cell, prostate, and urothelial malignancies.
Bracarda S; Altavilla A; Hamzaj A; Sisani M; Marrocolo F; Del Buono S; Danielli R
Semin Oncol; 2015 Jun; 42(3):495-505. PubMed ID: 25965369
[TBL] [Abstract][Full Text] [Related]
15. Immuno-Oncology Advances in Genitourinary Cancers.
Zang PD; Angeles A; Dorff TB; Pal SK; Gupta S
Am Soc Clin Oncol Educ Book; 2024 Jan; 44(2):e430428. PubMed ID: 38206274
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.
Aluwini S; Pos F; Schimmel E; Krol S; van der Toorn PP; de Jager H; Alemayehu WG; Heemsbergen W; Heijmen B; Incrocci L
Lancet Oncol; 2016 Apr; 17(4):464-474. PubMed ID: 26968359
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
Pruthi RS; Derksen E; Gaston K
J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
[TBL] [Abstract][Full Text] [Related]
18. Highlights from the Society of Urologic Oncology, 5th Annual Meeting, December 3-4, 2004, Bethesda, Maryland, United States of America.
Grubb RL; Behari A; Kim CM; Williams CR; Linehan WM; Coleman JA
J Urol; 2005 Dec; 174(6):2330-3. PubMed ID: 16280834
[TBL] [Abstract][Full Text] [Related]
19. Highlights in Metastatic Prostate Cancer From the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: Commentary.
Shore ND
Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 5):17-9. PubMed ID: 27167847
[No Abstract] [Full Text] [Related]
20. Inside prostate cancer news from the 2021 ASCO Genitourinary Cancers Symposium.
Iacovelli R; Astore S; Ciccarese C; Cannella MA; Bove P; Iacovelli V; Tortora G
Expert Rev Anticancer Ther; 2021 Nov; 21(11):1207-1210. PubMed ID: 34493147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
